Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy
NCT01539681
·
clinicaltrials.gov ↗
COMPLETED
Status
234
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Sorafenib (Nexavar, BAY43-9006)
Sponsor
Bayer